GE HealthCare Technologies Inc. $GEHC Shares Acquired by Jefferies Financial Group Inc.

Jefferies Financial Group Inc. grew its stake in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 56.1% in the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 371,013 shares of the company’s stock after buying an additional 133,360 shares during the quarter. Jefferies Financial Group Inc. owned approximately 0.08% of GE HealthCare Technologies worth $24,253,000 as of its most recent SEC filing.

Several other institutional investors have also recently made changes to their positions in the stock. First Command Advisory Services Inc. raised its stake in GE HealthCare Technologies by 226.1% during the 3rd quarter. First Command Advisory Services Inc. now owns 1,784 shares of the company’s stock worth $117,000 after acquiring an additional 1,237 shares during the period. Northbridge Financial Group LLC lifted its holdings in GE HealthCare Technologies by 15.5% during the third quarter. Northbridge Financial Group LLC now owns 8,446 shares of the company’s stock valued at $547,000 after purchasing an additional 1,132 shares in the last quarter. Lido Advisors LLC boosted its position in shares of GE HealthCare Technologies by 90.3% in the third quarter. Lido Advisors LLC now owns 25,613 shares of the company’s stock worth $1,674,000 after purchasing an additional 12,157 shares during the period. New York Life Investment Management LLC increased its stake in shares of GE HealthCare Technologies by 6.1% in the third quarter. New York Life Investment Management LLC now owns 67,027 shares of the company’s stock worth $4,382,000 after purchasing an additional 3,844 shares in the last quarter. Finally, Gen Wealth Partners Inc increased its stake in shares of GE HealthCare Technologies by 37.1% in the third quarter. Gen Wealth Partners Inc now owns 16,891 shares of the company’s stock worth $1,104,000 after purchasing an additional 4,570 shares in the last quarter. Institutional investors own 82.06% of the company’s stock.

GE HealthCare Technologies Trading Down 1.3%

Shares of GEHC opened at $82.60 on Thursday. The company has a debt-to-equity ratio of 0.86, a current ratio of 1.30 and a quick ratio of 1.01. GE HealthCare Technologies Inc. has a 1 year low of $58.75 and a 1 year high of $89.77. The company has a 50 day simple moving average of $70.06 and a two-hundred day simple moving average of $70.09. The firm has a market cap of $37.35 billion, a P/E ratio of 17.43, a price-to-earnings-growth ratio of 2.11 and a beta of 0.65.

GE HealthCare Technologies (NASDAQ:GEHC) last released its quarterly earnings data on Wednesday, October 28th. The company reported $1.34 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.20 by $0.14. GE HealthCare Technologies had a net margin of 9.96% and a return on equity of 20.45%. The firm had revenue of $5.51 billion for the quarter, compared to analysts’ expectations of $5.35 billion. During the same quarter last year, the business posted $1.07 earnings per share. The company’s revenue for the quarter was up 7.2% compared to the same quarter last year. On average, equities analysts expect that GE HealthCare Technologies Inc. will post 5.02 earnings per share for the current fiscal year.

GE HealthCare Technologies Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, November 13th. Investors of record on Friday, October 23rd will be paid a dividend of $0.04 per share. The ex-dividend date of this dividend is Friday, October 23rd. This is a positive change from GE HealthCare Technologies’s previous quarterly dividend of $0.0350. This represents a $0.16 annualized dividend and a yield of 0.2%. GE HealthCare Technologies’s dividend payout ratio is 3.38%.

Wall Street Analyst Weigh In

Several brokerages recently weighed in on GEHC. Argus upped their target price on shares of GE HealthCare Technologies from $85.00 to $110.00 and gave the stock a “buy” rating in a report on Wednesday. Piper Sandler reiterated a “buy” rating on shares of GE HealthCare Technologies in a research note on Wednesday, July 29th. Wells Fargo & Company raised their price target on GE HealthCare Technologies from $75.00 to $85.00 and gave the company an “overweight” rating in a report on Thursday, July 30th. Hovde Group assumed coverage on GE HealthCare Technologies in a research report on Friday, July 17th. They issued a “market perform” rating and a $14.00 price objective on the stock. Finally, Weiss Ratings upgraded GE HealthCare Technologies from a “hold (c-)” rating to a “hold (c)” rating in a research report on Tuesday, October 6th. Twelve equities research analysts have rated the stock with a Buy rating and eleven have assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, GE HealthCare Technologies has an average rating of “Moderate Buy” and an average target price of $82.17.

About GE HealthCare Technologies

GE HealthCare Technologies Inc. is a global medical technology company that develops and provides equipment, software and services for healthcare providers. Its offerings support medical imaging, diagnosis, patient monitoring and treatment across a range of clinical settings. The company’s products include magnetic resonance imaging, computed tomography, molecular imaging and ultrasound systems, as well as patient monitoring and care solutions. Its Pharmaceutical Diagnostics business supplies contrast agents and radiopharmaceuticals used in medical imaging.